CSIMarket
 


Travere Therapeutics Inc   (TVTX)
Other Ticker:  
 

Cumulative Travere Therapeutics Inc 's Working Capital Ratio for Trailing Twelve Months Period

TVTX's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TVTX Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 15.79 % 56.25 % 73.62 % 86.53 % 82.72 %
Y / Y Current Assets Growth -7.64 % 6.73 % 11.69 % 17.11 % 14.54 %
Working Capital Ratio for Trailing Twelve Months Period 4.68 4.95 5.37 5.9 6.68
Total Ranking # 937 # 1118 # 1102 # 1121 # 794
Seq. Current Liabilities Growth 5.25 % 4.2 % -3.72 % 9.65 % 42.03 %
Seq. Current Assets Growth -8.85 % -7.02 % 8.28 % 0.65 % 5.33 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $131 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 4.68 below Travere Therapeutics Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 286 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Travere Therapeutics Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 937, from total ranking in previous quarter at 1118.

What is Working Capital Ratio?
More about TVTX
Working Capital Ratio TVTX in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 287
Sector # 522
S&P 500 # 936


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
6.62 4.69 2.34
(Mar 31 2021)   (Dec. 30, 2015)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Avidity Biosciences Inc   12.86 
Iveric Bio Inc   12.84 
Virpax Pharmaceuticals Inc   12.83 
Cormedix Inc   12.66 
Oncternal Therapeutics Inc   12.63 
Pliant Therapeutics Inc   12.46 
Capricor Therapeutics inc   12.46 
Lyell Immunopharma Inc   12.45 
Cogent Biosciences Inc   12.44 
Inozyme Pharma Inc   12.32 
Aclaris Therapeutics Inc   12.31 
Acrivon Therapeutics Inc   12.31 
Viracta Therapeutics Inc   12.27 
Pyxis Oncology Inc   12.20 
Gracell Biotechnologies Inc   12.15 
Assembly Biosciences Inc   12.11 
Synlogic Inc   12.10 
Bioxcel Therapeutics Inc   12.05 
Trillium Therapeutics Inc   12.04 
Pepgen Inc   11.93 
Liquidia Corporation  11.86 
Satsuma Pharmaceuticals Inc   11.86 
Igm Biosciences Inc   11.76 
Vanda Pharmaceuticals Inc   11.67 
Aurinia Pharmaceuticals Inc   11.66 
Citius Pharmaceuticals Inc   11.63 
Processa Pharmaceuticals Inc   11.56 
Tonix Pharmaceuticals Holding Corp   11.54 
Cymabay Therapeutics Inc   11.42 
Matinas Biopharma Holdings Inc   11.31 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JACK's Profile

Stock Price

JACK's Financials

Business Description

Fundamentals

Charts & Quotes

JACK's News

Suppliers

JACK's Competitors

Customers & Markets

Economic Indicators

JACK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071